Janus Henderson Group PLC Amicus Therapeutics, Inc. Transaction History

Janus Henderson Group PLC

$182 Billion
Q2 2024

A detailed history of Janus Henderson Group PLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 13,231,394 shares of FOLD stock, worth $145 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

13,231,394

Previous 13,814,514 4.22%

Holding current value

$145 Million

Previous $163 Million 19.34%

% of portfolio

0.07%

Previous 0.09%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$9.04 - $11.75 $5.27 Million - $6.85 Million	-583,120 Reduced 4.22%	13,231,394 $131 Million
Q1 2024 May 15, 2024	BUY	$11.43 - $14.24 $26.4 Million - $32.9 Million	2,307,385 Added 20.05%	13,814,514 $163 Million
Q4 2023 Feb 14, 2024	SELL	$9.97 - $14.52 $34.2 Million - $49.8 Million	-3,426,892 Reduced 22.95%	11,507,129 $163 Million
Q3 2023 Nov 14, 2023	BUY	$11.78 - $13.86 $122,900 - $144,601	10,433 Added 0.07%	14,934,021 $182 Million
Q2 2023 Aug 14, 2023	BUY	$10.72 - $13.3 $14.1 Million - $17.5 Million	1,313,153 Added 9.65%	14,923,588 $187 Million
Q1 2023 May 15, 2023	SELL	$10.91 - $13.54 $917,683 - $1.14 Million	-84,114 Reduced 0.61%	13,610,435 $151 Million
Q4 2022 Feb 14, 2023	SELL	$9.89 - $12.7 $10.7 Million - $13.7 Million	-1,081,566 Reduced 7.32%	13,694,549 $167 Million
Q3 2022 Nov 14, 2022	SELL	$9.82 - $12.75 $19.7 Million - $25.6 Million	-2,004,026 Reduced 11.94%	14,776,115 $154 Million
Q2 2022 Aug 15, 2022	BUY	$6.23 - $11.12 $7.21 Million - $12.9 Million	1,157,528 Added 7.41%	16,780,141 $180 Million
Q1 2022 May 16, 2022	BUY	$7.89 - $12.48 $45.5 Million - $71.9 Million	5,764,732 Added 58.48%	15,622,613 $148 Million
Q4 2021 Feb 14, 2022	BUY	$9.82 - $12.44 $27.5 Million - $34.9 Million	2,803,673 Added 39.74%	9,857,881 $114 Million
Q3 2021 Nov 16, 2021	BUY	$8.74 - $11.84 $18.1 Million - $24.5 Million	2,065,621 Added 41.41%	7,054,208 $67.4 Million
Q2 2021 Aug 16, 2021	SELL	$8.71 - $10.72 $34.8 Million - $42.8 Million	-3,995,468 Reduced 44.47%	4,988,587 $48.1 Million
Q1 2021 May 17, 2021	SELL	$9.2 - $23.86 $20.8 Million - $54 Million	-2,263,153 Reduced 20.12%	8,984,055 $88.8 Million
Q4 2020 Feb 16, 2021	SELL	$13.47 - $24.89 $38.5 Million - $71.2 Million	-2,859,051 Reduced 20.27%	11,247,208 $260 Million
Q3 2020 Nov 16, 2020	BUY	$12.89 - $15.89 $29.8 Million - $36.7 Million	2,312,500 Added 19.61%	14,106,259 $199 Million
Q2 2020 Aug 14, 2020	BUY	$8.86 - $15.69 $1.49 Million - $2.63 Million	167,835 Added 1.44%	11,793,759 $178 Million
Q1 2020 May 14, 2020	BUY	$6.63 - $11.16 $5.75 Million - $9.68 Million	867,308 Added 8.06%	11,625,924 $107 Million
Q4 2019 Feb 18, 2020	SELL	$7.48 - $10.75 $1.4 Million - $2.02 Million	-187,619 Reduced 1.71%	10,758,616 $105 Million
Q3 2019 Nov 14, 2019	BUY	$8.02 - $13.25 $587,513 - $970,642	73,256 Added 0.67%	10,946,235 $87.8 Million
Q2 2019 Jul 31, 2019	SELL	$10.96 - $14.4 $2.01 Million - $2.64 Million	-183,163 Reduced 1.66%	10,872,979 $136 Million
Q1 2019 Apr 30, 2019	SELL	$10.04 - $13.92 $175,117 - $242,792	-17,442 Reduced 0.16%	11,056,142 $150 Million
Q4 2018 Feb 06, 2019	BUY	$8.38 - $13.44 $19 Million - $30.5 Million	2,267,225 Added 25.75%	11,073,584 $106 Million
Q3 2018 Nov 09, 2018	BUY	$11.6 - $16.54 $7.28 Million - $10.4 Million	627,972 Added 7.68%	8,806,359 $106 Million
Q2 2018 Aug 10, 2018	SELL	$13.13 - $17.09 $4.83 Million - $6.29 Million	-367,952 Reduced 4.31%	8,178,387 $128 Million
Q1 2018 May 14, 2018	BUY	$13.76 - $17.12 $8.66 Million - $10.8 Million	629,638 Added 7.95%	8,546,339 $129 Million
Q4 2017 Feb 09, 2018	BUY	$12.51 - $16.24 $6.03 Million - $7.83 Million	482,387 Added 6.49%	7,916,701 $114 Million
Q3 2017 Nov 14, 2017	BUY	$11.74 - $15.78 $4.78 Million - $6.43 Million	407,304 Added 5.8%	7,434,314 $0
Q2 2017 Aug 17, 2017	BUY	N/A	7,027,010	7,027,010 $70.8 Million

Others Institutions Holding FOLD

# of Institutions

288

Shares Held

321M

Call Options Held

260K

Put Options Held

261K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $3.08B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Amicus Therapeutics, Inc. Transaction History